Skip to content
10-Q

Quarterly Report

Relay Therapeutics, Inc. RLAY

0001193125-25-269601

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 173.32M sh
Capex Q3 2025 · Sep 30, 2025 $409K
Capex Q3 2025 · Sep 30, 2024 $2.02M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$190.59M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$191.24M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $91.56M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $124.29M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $152.36M
Stockholders Equity Q3 2025 · Sep 30, 2025 $607.71M
Stockholders Equity Q3 2025 · Jun 30, 2025 $665.66M
Stockholders Equity Q3 2025 · Mar 31, 2025 $721.08M
Stockholders Equity Q3 2025 · Dec 31, 2024 $777.79M
Stockholders Equity Q3 2025 · Sep 30, 2024 $838.86M
Stockholders Equity Q3 2025 · Jun 30, 2024 $681.74M
Stockholders Equity Q3 2025 · Mar 31, 2024 $745.76M
Stockholders Equity Q3 2025 · Dec 31, 2023 $752M
Current Liabilities Q3 2025 · Sep 30, 2025 $32.61M
Current Liabilities Q3 2025 · Dec 31, 2024 $50.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $62.29M
Total Liabilities Q3 2025 · Dec 31, 2024 $93.5M
Current Assets Q3 2025 · Sep 30, 2025 $624.01M
Current Assets Q3 2025 · Dec 31, 2024 $809.2M
Total Assets Q3 2025 · Sep 30, 2025 $670M
Total Assets Q3 2025 · Dec 31, 2024 $871.3M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.43
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.30
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.63
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.94
Eps Basic Q3 2025 · Sep 30, 2025 −$0.43
Eps Basic Q3 2025 · Sep 30, 2025 −$1.30
Eps Basic Q3 2025 · Sep 30, 2024 −$0.63
Eps Basic Q3 2025 · Sep 30, 2024 −$1.94
Sga Expense Q3 2025 · Sep 30, 2025 $12.13M
Sga Expense Q3 2025 · Sep 30, 2025 $44.5M
Sga Expense Q3 2025 · Sep 30, 2024 $19.75M
Sga Expense Q3 2025 · Sep 30, 2024 $59.69M
Net Income Q3 2025 · Sep 30, 2025 −$74.15M
Net Income Q3 2025 · Sep 30, 2025 −$221.59M
Net Income Q3 2025 · Jun 30, 2025 −$70.38M
Net Income Q3 2025 · Mar 31, 2025 −$77.07M
Net Income Q3 2025 · Sep 30, 2024 −$88.11M
Net Income Q3 2025 · Sep 30, 2024 −$261.7M
Net Income Q3 2025 · Jun 30, 2024 −$92.21M
Net Income Q3 2025 · Mar 31, 2024 −$81.39M
Operating Income Q3 2025 · Sep 30, 2025 −$80.39M
Operating Income Q3 2025 · Sep 30, 2025 −$242.11M
Operating Income Q3 2025 · Sep 30, 2024 −$96.37M
Operating Income Q3 2025 · Sep 30, 2024 −$287.49M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $8.36M
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $10.01M